IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients With Relapsed Small Cell Lung Cancer - Merck.com

by /u/WalkingHorse in /r/LungCancerSupport

Upvotes: 1

Favorite this post:

Mark as read:

Your rating:

Add this post to a custom list